Meldonium: Optimize Cellular Energy and Ischemic Protection
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.51 | $50.20 (0%) | 🛒 Add to cart |
| 30 | $2.31 | $75.30 $69.28 (8%) | 🛒 Add to cart |
| 60 | $2.01 | $150.60 $120.48 (20%) | 🛒 Add to cart |
| 90 | $1.51 | $225.90 $135.54 (40%) | 🛒 Add to cart |
| 120 | $1.20 | $301.20 $144.58 (52%) | 🛒 Add to cart |
| 180 | $0.90 | $451.80 $162.65 (64%) | 🛒 Add to cart |
| 270 | $0.75 | $677.70 $203.81 (70%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $903.60 $216.86 (76%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.16 (0%) | 🛒 Add to cart |
| 20 | $3.61 | $80.32 $72.29 (10%) | 🛒 Add to cart |
| 30 | $3.21 | $120.48 $96.38 (20%) | 🛒 Add to cart |
| 60 | $2.81 | $240.96 $168.67 (30%) | 🛒 Add to cart |
| 90 | $2.01 | $361.44 $180.72 (50%) | 🛒 Add to cart |
| 120 | $1.61 | $481.92 $192.77 (60%) | 🛒 Add to cart |
| 180 | $1.20 | $722.88 $216.86 (70%) | 🛒 Add to cart |
| 270 | $1.00 | $1084.31 $271.08 (75%) | 🛒 Add to cart |
| 360 | $0.90
Best per pill | $1445.75 $325.29 (78%) | 🛒 Add to cart |
Synonyms | |||
Meldonium is a cardioprotective and anti-ischemic agent belonging to the class of fatty acid oxidation inhibitors. Its primary mechanism of action involves a shift in energy metabolism, promoting the more efficient use of glucose under conditions of oxygen deficiency (ischemia) and reducing the accumulation of toxic metabolites. This makes it a valuable therapeutic agent for a range of cardiovascular and neurological conditions where tissue perfusion is compromised. Its clinical application is supported by a body of research demonstrating its efficacy in improving functional capacity and reducing symptoms associated with ischemia.
Features
- Active Pharmaceutical Ingredient (API): Meldonium dihydrate.
- Pharmacotherapeutic Group: Other cardiac preparations, fatty acid oxidation inhibitors.
- Mechanism of Action: Competitive inhibition of gamma-butyrobetaine hydroxylase, the enzyme responsible for the final synthesis of L-carnitine.
- Primary Effect: Modulates energy metabolism by reducing the transport of long-chain fatty acids into mitochondria, shifting substrate utilization to the more oxygen-efficient glycolysis.
- Presentation: Available in oral (capsules, tablets) and parenteral (solution for injection) formulations.
- Standard Strengths: 250 mg and 500 mg capsules/tablets; 100 mg/mL injection solution.
Benefits
- Enhanced Cellular Protection: Shields cardiac and neural cells from damage caused by ischemia (inadequate blood supply) and hypoxia (oxygen deficiency).
- Improved Physical Performance and Recovery: Increases tolerance to physical exertion and reduces recovery time after intense workload by optimizing energy metabolism and reducing metabolic acidosis.
- Symptom Reduction: Effectively decreases the frequency and severity of angina pectoris attacks (chest pain) and symptoms of chronic heart failure, such as dyspnea (shortness of breath) and fatigue.
- Neuroprotective Support: Improves functional recovery and outcomes in cases of acute and chronic cerebrovascular insufficiency, including post-stroke rehabilitation.
- Increased Work Capacity: Supports sustained mental and physical performance under stressful conditions by maintaining efficient cellular energy production.
- Reduced Toxic Metabolite Accumulation: Limits the buildup of intermediary metabolites like acyl-CoA and acylcarnitine, which are detrimental to cell function during ischemia.
Common use
Meldonium is indicated for use in adults for the treatment and management of various conditions characterized by compromised blood flow and energy metabolism.
- Cardiology: Chronic heart failure (NYHA Class I-III), ischemic heart disease (stable angina pectoris, post-myocardial infarction), and cardiomyopathies. It is used to improve exercise tolerance and reduce functional limitations.
- Neurology: Acute and chronic cerebrovascular disorders, including recovery after stroke, cerebral infarction, and transient ischemic attacks (TIAs). It is also used for neuroasthenia and cognitive deficits of vascular origin.
- Other Applications: May be used as part of a complex therapy for retinal vascular disorders and to improve physical capacity and recovery in athletes (subject to relevant anti-doping regulations).
Dosage and direction
Dosage is individualized based on the patient’s condition, severity of symptoms, and the formulation used. The following represents common therapeutic regimens. Always adhere to the specific prescription provided by a healthcare professional.
- Oral Administration (Tablets/Capsules):
- The typical adult dose is 500 mg - 1000 mg per day, divided into 1-2 administrations.
- The usual course of treatment is 4-6 weeks. Courses may be repeated 2-3 times per year as directed by a physician.
- The medication is best taken before noon to avoid potential effects on sleep due to its activating properties.
- Intravenous Administration (Solution for Injection):
- Used for acute conditions or when oral administration is not feasible.
- The typical dose is 500 mg - 1000 mg (5 - 10 mL of the 100 mg/mL solution) administered once daily via intravenous drip or slow intravenous injection.
- The intravenous course usually lasts up to 10-14 days, often followed by a transition to oral maintenance therapy.
- General Direction: Do not crush or chew extended-release formulations. Swallow capsules and tablets whole with a sufficient amount of water.
Precautions
- Medical Supervision: This medication should be used under the supervision of a physician who can monitor its efficacy and tolerability.
- Renal and Hepatic Impairment: Use with caution in patients with severe impairment of renal or hepatic function. Dose adjustment may be necessary, though formal guidelines are limited due to the drug’s primarily renal excretion and low protein binding.
- Blood Pressure: Meldonium can cause mild hypotension (low blood pressure) or tachycardia (rapid heart rate). Blood pressure and heart rate should be monitored, especially at the beginning of therapy and in hypotensive individuals.
- Pregnancy and Lactation: The safety of meldonium during pregnancy and breastfeeding has not been established. Use is only permissible if the potential benefit to the mother justifies the potential risk to the fetus or infant. A thorough risk-benefit analysis by a physician is mandatory.
- Driving and Operating Machinery: While meldonium generally improves cognitive function, individual reactions may vary. Patients should exercise caution when driving or operating heavy machinery until they are certain the medication does not adversely affect their alertness.
Contraindications
Meldonium is contraindicated in patients with:
- Hypersensitivity: A known allergy to meldonium or any of the excipients in the formulation.
- Severe Hypertension: Significantly elevated blood pressure (e.g., exceeding 180/110 mmHg) that is not adequately controlled by antihypertensive therapy.
- Intracranial Pressure Elevation: Conditions associated with increased pressure inside the skull (e.g., due to trauma, tumors, or hemorrhage).
- Age Restriction: Safety and efficacy in children and adolescents under 18 years of age have not been established.
Possible side effect
Meldonium is generally well-tolerated. Side effects are usually mild to moderate and transient. The most commonly reported adverse reactions are:
- Cardiovascular: Palpitations, tachycardia, fluctuations in blood pressure (most commonly hypotension).
- Central Nervous System: Psychomotor agitation, emotional lability, sleep disturbances (insomnia or drowsiness), headache.
- Gastrointestinal: Dyspepsia, feeling of heaviness in the epigastric region, nausea, diarrhea.
- Allergic Reactions: Skin rash, itching, urticaria, erythema.
- Other: General weakness, a feeling of pressure in the chest.
Drug interaction
Formal interaction studies are limited. However, theoretical and observed interactions include:
- Other Cardiovascular Agents: May potentiate the effects of nitrates, beta-blockers, calcium channel blockers, and other antihypertensive drugs, increasing the risk of hypotension and bradycardia. Concurrent use requires careful monitoring of hemodynamic parameters.
- Glyceryl Trinitrate (Nitroglycerin): Meldonium can enhance the vasodilatory effect of nitroglycerin.
- Anticoagulants and Antiplatelets: Caution is advised when co-administering with drugs like warfarin or clopidogrel, as meldonium may influence hemostasis, though clinical data is sparse.
- CNS Depressants and Stimulants: Potential exists for interaction with drugs affecting the central nervous system.
Missed dose
- If a dose is missed, it should be taken as soon as it is remembered.
- However, if it is almost time for the next scheduled dose, the missed dose should be skipped.
- Do not take a double dose to make up for a forgotten one.
- Maintaining a regular dosing schedule is important for optimal therapeutic effect.
Overdose
Cases of overdose are rare. Symptoms are likely to be an extension of the drug’s known side effects and may include:
- Pronounced hypotension (dizziness, lightheadedness, fainting)
- Tachycardia or bradycardia
- Headache
- General weakness
- Nausea In case of suspected overdose, discontinue the medication immediately and seek urgent medical attention. Treatment is symptomatic and supportive. There is no known specific antidote for meldonium.
Storage
- Store in the original packaging to protect from light and moisture.
- Keep at a temperature not exceeding 25°C (77°F).
- Keep out of the reach and sight of children.
- Do not use after the expiration date printed on the packaging.
- Do not dispose of medication via wastewater or household waste. Consult your pharmacist on the proper disposal method to protect the environment.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on general characteristics of the drug and may not encompass all possible uses, directions, precautions, or interactions.
Reviews
- Cardiologist, 15 years experience: “I incorporate meldonium into the management plan for select patients with stable angina and CHF. The most consistent feedback is an improvement in exercise tolerance and a reduction in fatigue. It’s a useful adjunct therapy, particularly for patients who remain symptomatic on standard regimens.”
- Neurologist: “In our post-stroke rehabilitation unit, we have observed that patients on meldonium as part of their therapy often show better recovery of motor function and cognitive metrics compared to control groups. It appears to support neuroplasticity in the ischemic penumbra.”
- Patient with Chronic Heart Failure (NYHA Class II): “After starting this medication, the constant feeling of exhaustion lessened significantly. I can now take a short walk without becoming immediately breathless. It has given me a piece of my life back.”
- Clinical Pharmacologist: “Its mechanism is pharmacologically sound—shifting energy production to a more efficient pathway during stress. While more large-scale, randomized controlled trials are always welcome, the existing evidence and clinical experience support its niche in managing ischemic conditions.”